Ilaris 150 MG/ML vialml
Ended Awarded Last action
- Contract number
- SPE2DR26FCYY2
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $26,183
Award facts
- Contract value 100% obligated
- $26,182.60 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $26,182.60 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of ILARIS 150 mg/ml vials. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of December 19, 2025, and carries no set-aside designation, indicating the award was made through open competition. This delivery order is issued under DMS Pharmaceutical Group's Indefinite Delivery Contract (IDC) with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion government-wide acquisition strategy awarded on November 13, 2025, with a ceiling value of $499,999,999 extending through December 31, 2036.
DMS Pharmaceutical Group serves as a critical pharmaceutical supplier within the Defense Logistics Agency's Medical Supply Chain division, leveraging its established small business status to distribute a comprehensive range of pharmaceutical products including branded and generic prescription medications, biologics, vaccines, and medical consumables to Department of Defense healthcare facilities. The company's demonstrated performance across multiple product categories and delivery orders—ranging from under $100 to over $115,000—positions it as a capable vendor within the broader federal pharmaceutical supply network. ILARIS is a specialty biologic used for auto-inflammatory conditions and represents the type of specialized pharmaceutical product the company supplies to support military healthcare operations globally.
Quick answers
Who was awarded contract SPE2DR26FCYY2?
SPE2DR26FCYY2 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on November 28, 2025.
How much is contract SPE2DR26FCYY2 worth?
The government has obligated $26,183 on SPE2DR26FCYY2.
Is contract SPE2DR26FCYY2 an order under another contract?
Yes. SPE2DR26FCYY2 is a delivery order under SPE2DR25D9127, an indefinite delivery contract.
Was contract SPE2DR26FCYY2 competed?
The extent of competition for SPE2DR26FCYY2 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award